Squarepoint
VIRX

Squarepoint’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Squarepoint’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,098
Closed -$20.6K – 3040
2023
Q4 		$20.6K Buy
+36,098
New +$20.6K ﹤0.01% 2424